Skip to content

ACUPUNCTURE AND INTEGRATIVE MEDICINE

This is Alex Smithers.  I founded the Integral Medicine clinic in an attempt to bring an intelligent, practical, and refined integration of Conventional and Complementary, Western and Eastern medicine to the community.  My goal is to bring the patient into a state of balance as gently and comfortably as possible, while keeping the treatment plans as practical, as simple, and as cost effective as possible.  I believe that this is what enhances patient compliance and compliance is essential for positive outcomes.


The clinic will use an Integrative/Functional Medical approach to treat all forms of illness, disease and dysfunction.  At the same time, we will explore the broader implications of disease and shine light on how and why certain diseases originate and develop.

Founded on the principles of compassion, honesty and responsibility, Integral Medicine will engage in a new system of health care that is emerging in this country.  One based on actual health care rather than that of disease care.  A system in which the entire person is acknowledged in the treatment of disease rather than merely the symptoms they are presenting with.  Cooperation from both Eastern and Western practitioners will be necessary, however, as it is only in the integration of both of these systems, integrating the best of both worlds, that will offer the patient the most benefit.  This is the vision and hope of Dr. Smithers and Integral Medicine.

At Integral Medicine, we offer services to the greater Sarasota and Bradenton areas and treat a broad range of conditions.  We address all painful musculoskeletal conditions, primarily with Prolozone and Prolotherapy and treat everything from gastrointestinal conditions to chronic lyme and biotoxin illness.    Please call us if you have any questions or concerns.

Zelestrocel Stem Cell Therapy for Osteoarthritis Moves Toward Phase III

Zelestrocel Stem Cell Therapy for Osteoarthritis Moves Toward Phase III

Magellan Stem Cells, an Australian biotech, has partnered with Charles River Laboratories to support the next stage of Zelestrocel, an off-the-shelf allogeneic stem cell therapy for osteoarthritis. The company has completed Phase I/II studies and is preparing a pivotal Phase III program.

Table of Contents What Happened What Zelestrocel Continue reading

New Evidence Review: Acupuncture’s Role in Managing Chemotherapy-Induced Nerve Damage

New Evidence Review: Acupuncture’s Role in Managing Chemotherapy-Induced Nerve Damage

A new evidence-based clinical guide published October 1, 2026, synthesizes the latest research on managing chemotherapy-induced peripheral neuropathy (CIPN), identifying acupuncture as one of the few interventions with consistent evidence of benefit, while flagging a popular supplement that a major trial found actually worsens the condition.

Table of Contents Continue reading

FDA Grants RMAT Designation to CAR T Therapy Obe-Cel for Lupus and Lupus Nephritis

FDA Grants RMAT Designation to CAR T Therapy Obe-Cel for Lupus and Lupus Nephritis

The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to obecabtagene autoleucel (obe-cel), Autolus Therapeutics’ CAR T cell therapy, for the treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The designation, announced September 9, 2026, is based on Phase 1b data showing high Continue reading

941-444-6336 Directions